Will UnitedHealth Stock Recover?
Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…
Sell
17
OGI Quote, Financials, Valuation and Earnings
Last price:
$1.28
Seasonality move
:
2.26%
Day range:
$1.29 - $1.42
52-week range:
$0.85 - $2.24
Dividend yield:
0%
P/E ratio:
15.07x
P/S ratio:
0.88x
P/B ratio:
0.66x
Volume:
1.7M
Avg. volume:
881.1K
1-year change:
-9.03%
Market cap:
$177M
Revenue:
$185.4M
EPS (TTM):
$0.09
Analysts' Opinion
-
Consensus RatingOrganigram Global, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 4 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of --, Organigram Global, Inc. has an estimated upside of 148.86% from its current price of $1.31.
-
Price Target DownsideAccording to analysts, the lowest downside price target is -- representing 100% downside risk from its current price of $1.31.
Fair Value
-
According to the consensus of 5 analysts, Organigram Global, Inc. has 148.86% upside to fair value with a price target of -- per share.
OGI vs. S&P 500
-
Over the past 5 trading days, Organigram Global, Inc. has underperformed the S&P 500 by -15.6% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Organigram Global, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Organigram Global, Inc. has grown year-over-year revenues for 5 quarters straight. In the most recent quarter Organigram Global, Inc. reported revenues of $45.6M.
Earnings Growth
-
Organigram Global, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Organigram Global, Inc. reported earnings per share of $0.10.
Enterprise value:
137.3M
EV / Invested capital:
0.50x
Price / LTM sales:
0.88x
EV / EBIT:
--
EV / Revenue:
0.68x
PEG ratio (5yr expected):
-0.01x
EV / Free cash flow:
-5.25x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
38.27x
Gross Profit (TTM):
$9.9M
Return On Assets:
3.09%
Net Income Margin (TTM):
5.88%
Return On Equity:
4.54%
Return On Invested Capital:
4.43%
Operating Margin:
-31.68%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Income Statement | ||||||
| Revenue | $114.5M | $121.2M | $200.5M | $30.6M | $45.6M | |
| Gross Profit | -$26.9M | -$3.1M | $9.9M | -$5.7K | $3.1M | |
| Operating Income | -$93.3M | -$59.4M | -$63.7M | -$14M | -$14.4M | |
| EBITDA | -$76.8M | -$50.2M | -$49.7M | -$11.6M | -$10.9M | |
| Diluted EPS | -$2.47 | -$0.38 | $0.09 | -$0.14 | $0.10 | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | $121.6M | $161M | $187.2M | |
| Total Assets | -- | -- | $226.8M | $333.2M | $387.1M | |
| Current Liabilities | -- | -- | $28.4M | $47.9M | $68.6M | |
| Total Liabilities | -- | -- | $31.2M | $108.2M | $117.6M | |
| Total Equity | -- | -- | $195.5M | $225M | $269.5M | |
| Total Debt | -- | -- | $103.1K | $6.9M | $6.2M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-12-31 | 2024-12-31 | 2025-12-31 | 2024-12-31 | 2025-12-31 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$23.2M | -$3M | -$13.4M | -$2.3M | -$11.3M | |
| Cash From Investing | $2.7M | -$75.6M | -$19.8M | -$44.7M | -$3.3M | |
| Cash From Financing | -$569.3K | $79.4M | $28.4M | -$144.4K | -$322.7K | |
| Free Cash Flow | -$40.6M | -$6.7M | -$26.1M | -$3.5M | -$12.8M | |
OGI
Sector
Market Cap
$177M
$23.4M
Price % of 52-Week High
58.48%
48.88%
Dividend Yield
0%
0%
Shareholder Yield
-13.43%
-1.64%
1-Year Price Total Return
-9.03%
-21.81%
Beta (5-Year)
1.601
0.504
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$1.49
200-day SMA
Sell
Level
$1.56
Bollinger Bands (100)
Sell
Level
1.54 - 1.86
Chaikin Money Flow
Sell
Level
-3.8M
20-day SMA
Sell
Level
$1.56
Relative Strength Index (RSI14)
Sell
Level
32.14
ADX Line
Sell
Level
15.55
Williams %R
Buy
Level
-94.7368
50-day SMA
Sell
Level
$1.67
MACD (12, 26)
Buy
Level
0.40
25-day Aroon Oscillator
Sell
Level
-16
On Balance Volume
Sell
Level
-3.5M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-0.1646)
Buy
CA Score
(Annual)
Level (-0.2566)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (6)
Sell
Ohlson Score
Level (0.6781)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (4)
Buy
Fundamental Score
Level (3)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Organigram Global, Inc. engages in the provision of high-quality, indoor-grown cannabis for patients and adult recreational consumers and developing international business partnerships to extend the company’s global footprint. Its brands include Edison, Big Bag O’ Buds, SHRED, Monjour, and Trailblazer. The company was founded on July 5, 2010 and is headquartered in Toronto, Canada.
Stock Forecast FAQ
In the current month, OGI has received 4 Buy ratings 1 Hold ratings, and 0 Sell ratings. The OGI average analyst price target in the past 3 months is --.
-
Where Will Organigram Global, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Organigram Global, Inc. share price will rise to -- per share over the next 12 months.
-
What Do Analysts Say About Organigram Global, Inc.?
Analysts are divided on their view about Organigram Global, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Organigram Global, Inc. is a Sell and believe this share price will drop from its current level to --.
-
What Is Organigram Global, Inc.'s Price Target?
The price target for Organigram Global, Inc. over the next 1-year time period is forecast to be -- according to 5 Wall Street analysts, 4 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is OGI A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Organigram Global, Inc. is a Buy. 4 of 5 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of OGI?
You can purchase shares of Organigram Global, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Organigram Global, Inc. shares.
-
What Is The Organigram Global, Inc. Share Price Today?
Organigram Global, Inc. was last trading at $1.28 per share. This represents the most recent stock quote for Organigram Global, Inc.. Yesterday, Organigram Global, Inc. closed at $1.31 per share.
-
How To Buy Organigram Global, Inc. Stock Online?
In order to purchase Organigram Global, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get OGI Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
OGI
Sector
P/E ratio
15.07x
23.34x
PEG ratio
-0.01x
-0.01x
P/B ratio
0.66x
1.72x
Price / LTM sales
0.88x
1.51x
Growth Metrics
OGI
Sector
Revenue growth
49.13%
3.21%
Earnings growth
172.51%
10.12%
Revenue (5-year growth)
23.51%
6.27%
Earnings forecast
-$0.01
-$0.19
Profitability
OGI
Sector
Profitability FY 2025
$6.8M
$2.7M
Return on invested capital
4.43%
-33.62%
Return on assets
3.09%
-29.68%
Return on equity
4.54%
-38.89%
Earnings Date
Last Earnings Date
Feb
10
Next Earnings Date
May
13
Estimated Next Earnings Date
May
12
Balance Sheet
OGI
Sector
Total cash
$45.9M
$25M
Short term investments
$607.7K
$23.9M
Total assets
$404.1M
$72.8M
Long term debt
$6.2M
$2.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Lumentum The Best Laser Stock to Buy?
Though certainly less well-known than the huge tech businesses that…
Is Planet Fitness Stock Undervalued?
Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…
Stock Ideas
Buy
56
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 65x
Buy
58
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Sell
40
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
91
TDC alert for Feb 12
Teradata Corp. [TDC] is down 11.64% over the past day.
Buy
67
DIOD alert for Feb 12
Diodes, Inc. [DIOD] is down 7.63% over the past day.
Buy
77
VRT alert for Feb 12
Vertiv Holdings Co. [VRT] is down 4.79% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
